Abstract
For the purpose of studying a possible genetic marker for asthma, IgE levels and methacholine inhalation challenge responses were studied in 45 pairs of monozygous (MZ) twins and 28 pairs of dizygous (DZ) twins. The population under study was ascertained on the basis of living within a 300 mile radius of Omaha and being between ages 6 to 30. The zygosity was determined using a questionnaire, morphological markers, and 9 blood genetic markers including HLA. History of asthma, hay fever, or atopic eczema showed that 40.0% of the MZ twins were concordant for these diseases and 8.9% were discordant, while 17.9% of the DZ twins were concordant and discordant each. A x2 analysis of the distribution showed that there was a significant increase in the concordance for asthma, hay fever, and atopic eczema among the MZ twins when compared with DZ twins (p0.05) in DZ twins. The results on the methacholine inhalation response as measured by the area under a dose response curve showed a correlation coefficient of 0.73 (p
| Original language | English |
|---|---|
| Journal | American Review of Respiratory Disease |
| Volume | 113 |
| Issue number | 4 |
| State | Published - 1976 |
Fingerprint
All Science Journal Classification (ASJC) codes
- Pulmonary and Respiratory Medicine
Cite this
IgE levels and methacholine inhalation responses in monozygous and dizygous twins. / Townley, R.; Guirgis, H.; Bewtra, Againdra K.
In: American Review of Respiratory Disease, Vol. 113, No. 4, 1976.Research output: Contribution to journal › Article
}
TY - JOUR
T1 - IgE levels and methacholine inhalation responses in monozygous and dizygous twins
AU - Townley, R.
AU - Guirgis, H.
AU - Bewtra, Againdra K.
PY - 1976
Y1 - 1976
N2 - For the purpose of studying a possible genetic marker for asthma, IgE levels and methacholine inhalation challenge responses were studied in 45 pairs of monozygous (MZ) twins and 28 pairs of dizygous (DZ) twins. The population under study was ascertained on the basis of living within a 300 mile radius of Omaha and being between ages 6 to 30. The zygosity was determined using a questionnaire, morphological markers, and 9 blood genetic markers including HLA. History of asthma, hay fever, or atopic eczema showed that 40.0% of the MZ twins were concordant for these diseases and 8.9% were discordant, while 17.9% of the DZ twins were concordant and discordant each. A x2 analysis of the distribution showed that there was a significant increase in the concordance for asthma, hay fever, and atopic eczema among the MZ twins when compared with DZ twins (p0.05) in DZ twins. The results on the methacholine inhalation response as measured by the area under a dose response curve showed a correlation coefficient of 0.73 (p
AB - For the purpose of studying a possible genetic marker for asthma, IgE levels and methacholine inhalation challenge responses were studied in 45 pairs of monozygous (MZ) twins and 28 pairs of dizygous (DZ) twins. The population under study was ascertained on the basis of living within a 300 mile radius of Omaha and being between ages 6 to 30. The zygosity was determined using a questionnaire, morphological markers, and 9 blood genetic markers including HLA. History of asthma, hay fever, or atopic eczema showed that 40.0% of the MZ twins were concordant for these diseases and 8.9% were discordant, while 17.9% of the DZ twins were concordant and discordant each. A x2 analysis of the distribution showed that there was a significant increase in the concordance for asthma, hay fever, and atopic eczema among the MZ twins when compared with DZ twins (p0.05) in DZ twins. The results on the methacholine inhalation response as measured by the area under a dose response curve showed a correlation coefficient of 0.73 (p
UR - http://www.scopus.com/inward/record.url?scp=0017175344&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0017175344&partnerID=8YFLogxK
M3 - Article
AN - SCOPUS:0017175344
VL - 113
JO - American Journal of Respiratory and Critical Care Medicine
JF - American Journal of Respiratory and Critical Care Medicine
SN - 1073-449X
IS - 4
ER -